In chronic myeloid leukemia, a relevant decrease in imatinib clearance was associated with variant alleles of ABCB1 and SLCO1B3 [105]. This evidence concerns the gene SLCO1B3 and chronic myelogenous leukemia, BCR-ABL1 positive.